190 374

Cited 4 times in

Setting a health policy research agenda for controlling cancer burden in Korea

DC Field Value Language
dc.contributor.author박은철-
dc.contributor.author이광식-
dc.contributor.author장성인-
dc.date.accessioned2016-02-04T11:13:22Z-
dc.date.available2016-02-04T11:13:22Z-
dc.date.issued2015-
dc.identifier.issn1598-2998-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/139939-
dc.description.abstractPURPOSE: The aim of study was to provide suggestions for prioritizing research in effort to reduce cancer burden in Korea based on a comprehensive analysis of cancer burden and Delphi consensus among cancer experts. MATERIALS AND METHODS: Twenty research plans covering 10 topics were selected based on an assessment of the literature, and e-mail surveys were analyzed using a two-round modified Delphi method. Thirty-four out of 79 experts were selected from four organizations to participate in round one, and 21 experts among them had completed round two. Each item had two questions; one regarding the agreement of the topic as a priority item to reduce cancer burden, and the other about the importance of the item on a nine-point scale. A consensus was defined to be an average lower coefficient of variation with less than 30% in importance. RESULTS: Seven plans that satisfied the three criteria were selected as priority research plans for reducing cancer burden. These plans are "research into advanced clinical guidelines for thyroid cancer given the current issue with over-diagnosis," "research into smoking management plans through price and non-price cigarette policy initiatives," "research into ways to measure the quality of cancer care," "research on policy development to expand hospice care," "research into the spread and management of Helicobacter pylori," "research on palliative care in a clinical setting," and "research into alternative mammography methods to increase the accuracy of breast cancer screenings." CONCLUSION: The seven plans identified in this study should be prioritized to reduce the burden of cancer in Korea. We suggest that policy makers and administrators study and invest significant effort in these plans.-
dc.description.statementOfResponsibilityopen-
dc.format.extent149~157-
dc.relation.isPartOfCANCER RESEARCH AND TREATMENT-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleSetting a health policy research agenda for controlling cancer burden in Korea-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Preventive Medicine (예방의학)-
dc.contributor.googleauthorSung-In Jang-
dc.contributor.googleauthorKyoung-Hee Cho-
dc.contributor.googleauthorSun Jung Kim-
dc.contributor.googleauthorKwang-Sig Lee-
dc.contributor.googleauthorEun-Cheol Park-
dc.identifier.doi10.4143/crt.2013.167-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA02669-
dc.contributor.localIdA03439-
dc.contributor.localIdA01618-
dc.relation.journalcodeJ00453-
dc.identifier.eissn2005-9256-
dc.identifier.pmid25483749-
dc.subject.keywordAgenda-
dc.subject.keywordCancer burden-
dc.subject.keywordDelphi technique-
dc.subject.keywordEarly detection of cancer-
dc.subject.keywordHelicobacter pylori-
dc.subject.keywordHospices-
dc.subject.keywordPriority-
dc.subject.keywordResearch plan-
dc.subject.keywordThyroid neoplasms-
dc.contributor.alternativeNamePark, Eun Chul-
dc.contributor.alternativeNameLee, Kwang Sig-
dc.contributor.alternativeNameJang, Sung In-
dc.contributor.affiliatedAuthorLee, Kwang Sig-
dc.contributor.affiliatedAuthorJang, Sung In-
dc.contributor.affiliatedAuthorPark, Eun Chul-
dc.rights.accessRightsfree-
dc.citation.volume47-
dc.citation.number2-
dc.citation.startPage149-
dc.citation.endPage157-
dc.identifier.bibliographicCitationCANCER RESEARCH AND TREATMENT, Vol.47(2) : 149-157, 2015-
dc.identifier.rimsid48393-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Preventive Medicine (예방의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.